Dirk de Jong

7.6k total citations · 1 hit paper
15 papers, 1.9k citations indexed

About

Dirk de Jong is a scholar working on Genetics, Immunology and Epidemiology. According to data from OpenAlex, Dirk de Jong has authored 15 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 5 papers in Immunology and 4 papers in Epidemiology. Recurrent topics in Dirk de Jong's work include Inflammatory Bowel Disease (5 papers), Microscopic Colitis (4 papers) and IL-33, ST2, and ILC Pathways (2 papers). Dirk de Jong is often cited by papers focused on Inflammatory Bowel Disease (5 papers), Microscopic Colitis (4 papers) and IL-33, ST2, and ILC Pathways (2 papers). Dirk de Jong collaborates with scholars based in Netherlands, United States and Canada. Dirk de Jong's co-authors include Leo A. B. Joosten, Mihai G. Netea, J.W.M. van der Meer, Frank Preijers, Cor Jacobs, Ramnik J. Xavier, Hendrik G. Stunnenberg, Jessica Quintin, Reinout van Crevel and Daniela C. Ifrim and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Gastroenterology and PLoS ONE.

In The Last Decade

Dirk de Jong

15 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bacille Calmette-Guérin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes

2012 1.2k citations Johanneke Kleinnijenhuis, Jessica Quintin et al. Proceedings of the National Academy of Sciences profile →

Peers

Dirk de Jong

IMMUN

GENET

EPIDE

Johanneke Kleinnijenhuis Netherlands

Anna Zganiacz Canada

Laura Conejero Spain

Steven G. Smith United Kingdom

Sophie A. Valkenburg Hong Kong

Min Wu China

Chantal Tougne Switzerland

Stephen Cose Uganda

Meagan McMahon United States

Helen Horton United States

Johanneke Kleinnijenhuis Netherlands

Dirk de Jong

3.0k ×2.1

IMMUN

1.3k ×2.8

378 ×0.9

GENET

634 ×1.7

EPIDE

629 ×2.0

Citations per year, relative to Dirk de Jong Dirk de Jong (= 1×) peers Johanneke Kleinnijenhuis

Countries citing papers authored by Dirk de Jong

Since Specialization

Citations

This map shows the geographic impact of Dirk de Jong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk de Jong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk de Jong more than expected).

Fields of papers citing papers by Dirk de Jong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk de Jong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk de Jong. The network helps show where Dirk de Jong may publish in the future.

Co-authorship network of co-authors of Dirk de Jong

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk de Jong. A scholar is included among the top collaborators of Dirk de Jong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk de Jong. Dirk de Jong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Biemans, Vince, C. Janneke van der Woude, Gerard Dijkstra, et al.. (2020). Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn’s disease patients with prior failure to anti‐TNF treatment. Alimentary Pharmacology & Therapeutics. 52(1). 123–134. 76 indexed citations

Biemans, Vince, Andrea E. van der Meulen‐de Jong, C. Janneke van der Woude, et al.. (2019). Ustekinumab for Crohn’s Disease: Results of the ICC Registry, a Nationwide Prospective Observational Cohort Study. Journal of Crohn s and Colitis. 14(1). 33–45. 125 indexed citations

Marrewijk, Corine van, Dirk de Jong, Hans Scheffer, et al.. (2019). Genotype-Guided Thiopurine Dosing Does not Lead to Additional Costs in Patients With Inflammatory Bowel Disease. Journal of Crohn s and Colitis. 13(7). 838–845. 23 indexed citations

Bökkerink, Guus M.J., Gert Jan van der Wilt, Dirk de Jong, et al.. (2017). Value of macrobiopsies and transanal endoscopic microsurgery in the histological work-up of rectal neoplasms; a retrospective study. World Journal of Gastrointestinal Oncology. 9(6). 251–251. 4 indexed citations

Lachmandas, Ekta, Macarena Beigier‐Bompadre, Shih‐Chin Cheng, et al.. (2016). Rewiring cellular metabolism via the AKT/mTOR pathway contributes to host defence against Mycobacterium tuberculosis in human and murine cells. European Journal of Immunology. 46(11). 2574–2586. 107 indexed citations

Arts, Rob J.W., Bastiaan A. Blok, Peter Aaby, et al.. (2015). Long-term in vitro and in vivo effects of γ-irradiated BCG on innate and adaptive immunity. Journal of Leukocyte Biology. 98(6). 995–1001. 74 indexed citations

Oijen, Martijn G.H. van, Ad A. van Bodegraven, Gerard Dijkstra, et al.. (2013). Adalimumab and Infliximab Are Equally Effective for Crohn's Disease in Patients Not Previously Treated With Anti–Tumor Necrosis Factor-α Agents. Clinical Gastroenterology and Hepatology. 11(7). 826–831. 63 indexed citations

Kleinnijenhuis, Johanneke, Jessica Quintin, Frank Preijers, et al.. (2012). Bacille Calmette-Guérin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proceedings of the National Academy of Sciences. 109(43). 17537–17542. 1219 indexed citations breakdown →

Ferwerda, Bart, Matthew B. B. McCall, Maaike C. de Vries, et al.. (2009). Caspase-12 and the Inflammatory Response to Yersinia pestis. PLoS ONE. 4(9). e6870–e6870. 22 indexed citations

10.

Ferwerda, Gerben, Matthijs Kramer, Dirk de Jong, et al.. (2007). Engagement of NOD2 has a dual effect on proIL‐1β mRNA transcription and secretion of bioactive IL‐1β. European Journal of Immunology. 38(1). 184–191. 67 indexed citations

11.

Oostenbrug, Liekele E., Dirk de Jong, Joost P.H. Drenth, et al.. (2003). Lack of association between toll-like receptor 4 haplotype and Asp299gly polymorphism and susceptibility for inflammatory bowel disease. Gastroenterology. 124(4). A372–A373. 3 indexed citations

12.

Brouwers, Adrienne H., Dirk de Jong, E.T.M. Dams, et al.. (2000). Tc-99m-PEG-Liposomes for the Evaluation of Colitis in Crohn's Disease. Journal of drug targeting. 8(4). 225–233. 42 indexed citations

13.

Jong, Dirk de, et al.. (1987). The value of ^99m Tc macroaggregated albumin lung perfusion scanning in the prediction of postpneumonectomy function and pulmonary artery pressure. Scandinavian Journal of Thoracic and Cardiovascular Surgery. 21(1). 82–85. 6 indexed citations

14.

Oirschot, J.T. van, et al.. (1983). Effect of infections with swine fever virus on immune functions II. Lymphocyte response to mitogens and enumeration of lymphocyte subpopulations. Veterinary Microbiology. 8(1). 81–95. 28 indexed citations

15.

Oirschot, J.T. van, et al.. (1981). Effect of infections with swine fever virus on immune functions I. Response of lymphocytes from blood and lymphoid organs from infected and normal pigs to anti-immunoglobulin serum and protein A. Veterinary Microbiology. 6(1). 41–57. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact